Found 17 matching trials
Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED) PHASE3 The primary purpose of the study is to test the safety of HPV Vaccine in Wo...
Show More Location
Multiple Locations
Learn More & Join Trial
V501 Efficacy Study in Women Aged 18 to 26 (V501-027) PHASE2 A study to evaluate the efficacy, immunogenicity, safety and tolerability o...
Show More Location
Multiple Locations
Learn More & Join Trial
An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED) PHASE3 This is a China registration study. A randomized, double-blind, placebo-con...
Show More Location
Multiple Locations
Learn More & Join Trial
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) PHASE2 The purpose of this study is to evaluate the safety and immunogenicity of V...
Show More Location
Multiple Locations
Learn More & Join Trial
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) PHASE3 Data from this study are expected to demonstrate that Gardasil (V501, Human...
Show More Location
Multiple Locations
Learn More & Join Trial
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) PHASE3 The primary purpose of the study is to determine if GARDASIL (V501) with fo...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018) PHASE3 This study is to evaluate the safety, tolerability, and immune response of ...
Show More Location
Multiple Locations
Learn More & Join Trial
An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) PHASE3 This study was conducted to demonstrate that Gardasil™ (quadrivalent human ...
Show More Location
Multiple Locations
Learn More & Join Trial
V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028) PHASE2 The study evaluates the immunogenicity, safety and tolerability of V501 in ...
Show More Location
Multiple Locations
Learn More & Join Trial
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) PHASE3 The purpose of this study was to evaluate the safety, efficacy, and immunog...
Show More Location
Multiple Locations
Learn More & Join Trial